Fig. 5: The NIR-II imaging and MRI of YHM. | Light: Science & Applications

Fig. 5: The NIR-II imaging and MRI of YHM.

From: A nanotheranostic agent based on Nd3+-doped YVO4 with blood-brain-barrier permeability for NIR-II fluorescence imaging/magnetic resonance imaging and boosted sonodynamic therapy of orthotopic glioma

Fig. 5

a Vascular NIR-II images showing hindlimb of a C57BL/6J mouse (scale bar: 10 mm). b Measurement of the vessel width of the lateral thigh shown in (a) (orange solid line). c NIR-II imaging of C57BL/6 J mice orthotopic gliomas after injection of YHM and YH@MnO2 via the tail vein, scale bar: 5 mm. d T1-weighted in vitro MRI images of YHM compared with PBS ((i) pH 6.5 + 100 μM H2O2 + 1 mM GSH, (ii) pH 6.5). e Relaxation rate r1 versus the concentration of Mn

Back to article page